IP Group news 0

IP Group plc (LSE: IPO) (“IP Group” or "the Group"), which invests in breakthrough science and technology companies with the potential to create a better future for all, notes that portfolio company First Light Fusion Ltd (“First Light” or “the Company”) has announced a £25m successful first close of its latest funding round,

First Light, the UK’s inertial fusion energy company, noted the round was led by UK venture firm East X Ventures and its fusion fund Starmaker One with a significant strategic investment from the UK Atomic Energy Authority (UKAEA). It was also supported by existing shareholders including IP Group and our Hostplus managed fund. Following completion, IP Group has an undiluted beneficial holding of 28.3% in First Light, with a further 17.3% held via its managed funds*.

The capital will accelerate the commercial development of First Light Fusion’s groundbreaking FLARE Fusion Energy concept - a novel, reactor‑compatible approach to Inertial Fusion Energy, aimed at offering a simpler, lower cost, pathway to fusion energy.

Greg Smith, Chief Executive of IP Group, said: “First Light Fusion continues to make strong progress as it advances a highly differentiated and commercially focused approach to inertial fusion energy. The participation of specialist fusion investors alongside the UK Atomic Energy Authority is a strong endorsement of both the company’s technology and its strategic relevance to the UK’s long‑term energy ambitions. IP Group provides investors with access to differentiated deep‑science opportunities such as First Light. We continue to support the company as it accelerates development of its FLARE concept towards scalable, reactor‑compatible fusion.”

*Includes funds managed/advised on behalf of Hostplus.

 

For more information, please contact:

 

IP Group plc	www.ipgroupplc.com
Liz Vaughan-Adams, Communications	+44 (0) 20 7444 0062/+44 (0) 7967 312125
Portland
Lewis Bendall-Craft	+44 (0) 7931 973950

 

Notes for editors

 

About IP Group

 

IP Group accelerates the impact of science for a better future. As the most active UK based, early stage science and technology investor, we develop and support some of the world’s most exciting businesses in healthtech, deeptech and cleantech. Including through Parkwalk, the UK's largest growth EIS fund manager, we back world-changing innovation emerging in leading universities and research institutions. Our specialist investment team combines sector expertise with an international approach. Together we have a strong track record of success, having backed high-profile companies including Oxford Nanopore Technologies plc, Hinge Health, Featurespace, First Light Fusion, Hysata, and Oxa. IP Group is listed on the Main Market of the London Stock Exchange under the code IPO.

 

For more information, please visit our website at www.ipgroupplc.com.

 

ENDS